• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2018 Fiscal Year Final Research Report

Rice-derived protein hydrolysates as a source of dipeptidylpeptidase-IV inhibitory peptides for the management of type 2 diabetes.

Research Project

  • PDF
Project/Area Number 16K21534
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Eating habits
Food science
Research InstitutionShujitsu University

Principal Investigator

KAWAKAMI Kayoko  就実大学, 薬学部, 助教 (00505935)

Project Period (FY) 2016-04-01 – 2019-03-31
Keywords糖尿病 / 米タンパク加水分解物 / DPP-4 / 酸化ストレス
Outline of Final Research Achievements

In this study, anti-diabetic activities of rice-derived protein hydrolysates (RPH) were evaluated. RPH showed an inhibitory activity (IC50 = 1.5 ± 0.1 mg/mL) toward dipeptidylpeptidase-IV (DPP-4) that metabolizes the insulinotropic hormone, glucagon-like peptide-1. Further, we identified that the dipeptides Ile-Pro, Met-Pro, Val-Pro, and Leu-Pro from the RPH are involved in the inhibitory activity against DPP-4. Pancreatic beta-cell dysfunction is a major feature of type 2 diabetes. Previous studies have demonstrated that high glucose can increase the accumulation of intracellular reactive oxygen species (ROS) that results in oxidative stress to the beta-cells. Glutathione, the most abundant intracellular antioxidant, protects cells against ROS induced oxidative stress. We demonstrated that RPH showed increasing effect of the intracellular glutathione levels and the protective effect against oxidative stress.

Free Research Field

食品機能学

Academic Significance and Societal Importance of the Research Achievements

2型糖尿病は、膵β細胞からのインスリン分泌障害により発症・進展する疾患であり、膵β細胞の機能低下は2型糖尿病の発症に直結すると考えられている。本研究により、米タンパク加水分解物は日本においても新たな糖尿病治療ターゲットとなっているDPP-4阻害作用があることを明らかとした。また、米由来タンパク加水分解物は膵β細胞内グルタチオンを上昇させることにより、酸化ストレスによる細胞傷害抑制効果があることを見出した。以上の結果から、米由来タンパク加水分解物はDPP-4阻害作用によるインスリン量の調節とβ細胞保護作用により、糖尿病予防に対して相乗的な効果が期待できる。

URL: 

Published: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi